The DOI matches its OpenAlex record; 31 of the 31 references it cites were found in a registry or an index.
Relation Between the Time to Achieve the Lower Limit of the APTT Therapeutic Range and Recurrent Venous Thromboembolism During Heparin Treatment for Deep Vein Thrombosis
Abstract
BACKGROUND: Randomized trials have demonstrated the importance of achieving adequate heparinization early in the course of therapy. Recently, some authors reported a pooled analysis of selected studies in the literature that suggested that there is no convincing evidence that the risk of recurrent venous thromboembolism is critically dependent on achieving a therapeutic activated partial thromboplastin time result at 24 to 48 hours. METHODS: We provide the analyses of patient groups entered into our series of 3 consecutive double-blind randomized trials evaluating initial heparin therapy for proximal deep venous thrombosis. RESULTS: Logistic regression analysis of the patient groups receiving the less intense initial intravenous heparin dose of 30,000 U/24 h demonstrated that subtherapy for 24 hours predicted the onset of venous thromboembolic events. Failure to achieve a therapeutic activated partial thromboplastin time by 24 hours was associated with a 23.3% frequency of venous thromboembolism vs 4% to 6% for those whose activated partial thromboplastin time exceeded the therapeutic threshold by 24 hours (P=.02). Time-to-event analysis shows the increased frequency of recurrent venous thromboembolic events during the period of study in patients who were subtherapeutic for 24 hours compared with those who were therapeutic (P=.001). CONCLUSIONS: Our findings reaffirm the clinical importance of rapidly achieving therapeutic levels of heparin. Patients who failed to achieve the therapeutic threshold by 24 hours were at an increased risk of subsequent recurrent venous thromboembolism. These findings are independently supported by the results of a randomized trial comparing different intensities of initial heparin treatment by continuous infusion.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Meta-Analyses of Randomized Controlled Trials
Sacks, H. S., Berrier, J., Reitman, D., Ancona-Berk, V. A., & Chalmers, T. C. (1987) · New England Journal of Medicine · doi:10.1056/nejm198702193160806 · Cited by 1,250
Levine, M., Gent, M., Hirsh, J., Leclerc, J., Anderson, D., Weitz, J., Ginsberg, J., Turpie, A. G., Demers, C., Kovacs, M., et al. (1996) · New England Journal of Medicine · doi:10.1056/nejm199603143341101 · Cited by 1,192
Koopman, M. M. W., Prandoni, P., Piovella, F., Ockelford, P. A., Brandjes, D. P. M., van der Meer, J., Gallus, A. S., Simonneau, G., Chesterman, C. H., Prins, M. H., et al. (1996) · New England Journal of Medicine · doi:10.1056/nejm199603143341102 · Cited by 1,111
Raschke, R. A., Reilly, B. M., Guidry, J. R., Fontana, J. R., & Srinivas, S. (1993) · Annals of Internal Medicine · doi:10.7326/0003-4819-119-9-199311010-00002 · Cited by 743
Roentgen Diagnosis of Venous Thrombosis in the Leg
Rabinov, K. (1972) · Archives of Surgery · doi:10.1001/archsurg.1972.04180020014004 · Cited by 740
Different Intensities of Oral Anticoagulant Therapy in the Treatment of Proximal-Vein Thrombosis
Hull, R., Hirsh, J., Jay, R., Carter, C., England, C., Gent, M., Turpie, A. G. G., McLoughlin, D., Dodd, P., Thomas, M., et al. (1982) · New England Journal of Medicine · doi:10.1056/nejm198212303072704 · Cited by 728
Self-citationHull, R. D., Raskob, G. E., Hirsh, J., Jay, R. M., Leclerc, J. R., Geerts, W. H., Rosenbloom, D., Sackett, D. L., Anderson, C., Harrison, L., et al. (1986) · New England Journal of Medicine · doi:10.1056/nejm198610303151801 · Cited by 722
Self-citationHull, R. D., Raskob, G. E., Pineo, G. F., Green, D., Trowbridge, A. A., Elliott, C. G., Lerner, R. G., Hall, J., Sparling, T., Brettell, H. R., et al. (1992) · New England Journal of Medicine · doi:10.1056/nejm199204093261502 · Cited by 700
Self-citationBasu, D., Gallus, A., Hirsh, J., & Cade, J. (1972) · New England Journal of Medicine · doi:10.1056/nejm197208172870703 · Cited by 661
Warfarin Sodium versus Low-Dose Heparin in the Long-Term Treatment of Venous Thrombosis
Hull, R., Delmore, T., Genton, E., Hirsh, J., Gent, M., Sackett, D., McLoughlin, D., & Armstrong, P. (1979) · New England Journal of Medicine · doi:10.1056/nejm197910183011602 · Cited by 604
Self-citationPrandoni, P., Carta, M., Cogo, A., Ruol, A., Vigo, M., Casara, D., Lensing, A. W. A., Büller, H. R., & ten Cate, J. W. (1992) · The Lancet · doi:10.1016/0140-6736(92)91054-c · Cited by 583
Invited commentary: a critical look at some popular meta-analytic methods
Greenland, S. (1994) · American Journal of Epidemiology · doi:10.1093/oxfordjournals.aje.a117248 · Cited by 511
Heparin for 5 Days as Compared with 10 Days in the Initial Treatment of Proximal Venous Thrombosis
Hull, R. D., Raskob, G. E., Rosenbloom, D., Panju, A. A., Brill-Edwards, P., Ginsberg, J. S., Hirsh, J., Martin, G. J., & Green, D. (1990) · New England Journal of Medicine · doi:10.1056/nejm199005033221802 · Cited by 505
Self-citationBrandjes, D. P. M., Heijboer, H., Büller, H. R., de Rijk, M., Jagt, H., & ten Cate, J. W. (1992) · New England Journal of Medicine · doi:10.1056/nejm199211193272103 · Cited by 480
Adjusted Subcutaneous Heparin versus Warfarin Sodium in the Long-Term Treatment of Venous Thrombosis
Hull, R., Delmore, T., Carter, C., Hirsh, J., Genton, E., Gent, M., Turpie, G., & McLaughlin, D. (1982) · New England Journal of Medicine · doi:10.1056/nejm198201283060401 · Cited by 436
Self-citationManagement of Heparin Therapy: Controlled Prospective Trial
Salzman, E. W., Deykin, D., Shapiro, R. M., & Rosenberg, R. (1975) · New England Journal of Medicine · doi:10.1056/nejm197505152922002 · Cited by 435
Establishing a Therapeutic Range for Heparin Therapy
Brill-Edwards, P., Ginsberg, J. S., Johnston, M., & Hirsh, J. (1993) · Annals of Internal Medicine · doi:10.7326/0003-4819-119-2-199307150-00002 · Cited by 329
The Importance of Quality of Primary Studies in Producing Unbiased Systematic Reviews
Khan, K. S. (1996) · Archives of Internal Medicine · doi:10.1001/archinte.156.6.661 · Cited by 328
Gallus, A., Tillett, J., Jackaman, J., Mills, W., & Wycherley, A. (1986) · The Lancet · doi:10.1016/s0140-6736(86)91431-5 · Cited by 305
A standard heparin nomogram for the management of heparin therapy
Cruickshank, M. (1991) · Archives of Internal Medicine · doi:10.1001/archinte.151.2.333 · Cited by 266
Optimal Therapeutic Level of Heparin Therapy in Patients With Venous Thrombosis
Hull, R. D. (1992) · Archives of Internal Medicine · doi:10.1001/archinte.152.8.1589 · Cited by 260
Self-citationHÆMORRHAGIC COMPLICATIONS OF HEPARIN THERAPY
Mant, M., Thong, K. L., Birtwhistle, R., O'Brien, B., Hammond, G., & Grace, M. (1977) · The Lancet · doi:10.1016/s0140-6736(77)92388-1 · Cited by 242
Simonneau, G. (1993) · Archives of Internal Medicine · doi:10.1001/archinte.1993.00410130045005 · Cited by 232
The diagnosis of acute, recurrent, deep-vein thrombosis: a diagnostic challenge.
Hull, R. D., Carter, C. J., Jay, R. M., Ockelford, P. A., Hirsch, J., Turpie, A. G., Zielinsky, A., Gent, M., & Powers, P. J. (1983) · Circulation · doi:10.1161/01.cir.67.4.901 · Cited by 218
Self-citationRandomized Prospective Trial of Continuous vs Intermittent Heparin Therapy
Glazier, R. L. (1976) · JAMA: The Journal of the American Medical Association · doi:10.1001/jama.1976.03270130027021 · Cited by 205
Physician Practices in the Treatment of Pulmonary Embolism and Deep Venous Thrombosis
Wheeler, A. P. (1988) · Archives of Internal Medicine · doi:10.1001/archinte.1988.00380060085018 · Cited by 135
The Effectiveness of Implementing the Weight-Based Heparin Nomogram as a Practice Guideline
Raschke, R. A., Gollihare, B., & Peirce, J. C. (1996) · Archives of Internal Medicine · doi:10.1001/archinte.1996.00440140067006 · Cited by 120
Heparin therapy: A randomized prospective study
Wilson, J. R., & Lampman, J. H. (1979) · American Heart Journal · doi:10.1016/0002-8703(79)90349-1 · Cited by 116
Invited Commentary: Re: “A Critical Look at Some Popular Meta-Analytic Methods”
Olkin, I. (1994) · American Journal of Epidemiology · doi:10.1093/oxfordjournals.aje.a117249 · Cited by 115
Audit of control of heparin treatment.
Fennerty, A. G., Thomas, P. S., Backhouse, G., Bentley, P. G., Campbell, I. A., & Routledge, P. (1985) · BMJ · doi:10.1136/bmj.290.6461.27-a · Cited by 75
Cited by
Antithrombotic Therapy for Venous Thromboembolic Disease
Hyers, T. M., Agnelli, G., Hull, R. D., Morris, T. A., Samama, M., Tapson, V., & Weg, J. G. (2001) · Chest · doi:10.1378/chest.119.1_suppl.176s · Cited by 2,042
Self-citationAntithrombotic Therapy for Venous Thromboembolic Disease
Kearon, C., Kahn, S. R., Agnelli, G., Goldhaber, S., Raskob, G. E., & Comerota, A. J. (2008) · Chest · doi:10.1378/chest.08-0658 · Cited by 1,996
Heparin and Low-Molecular-Weight Heparin
Hirsh, J., Warkentin, T. E., Raschke, R., Granger, C., Ohman, E. M., & Dalen, J. E. (1998) · Chest · doi:10.1378/chest.114.5_supplement.489s · Cited by 1,031
Tapson, V. F. (2008) · New England Journal of Medicine · doi:10.1056/nejmra072753 · Cited by 1,024
Wood, K. E. (2002) · Chest · doi:10.1378/chest.121.3.877 · Cited by 718
Metadata
- Authors
- Hull, R. D.
- Venue
- Archives of Internal Medicine
- Publisher
- American Medical Association
- Published
- 1997-12-08
- Volume
- 157
- Issue
- 22
- Pages
- 2562-2562
- ISSN
- 0003-9926 (ISSN-L)
- OpenAlex
- W2001610776
- Cited by
- 261
- References
- 31
- FWCI
- 9.08
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.